Term Care Market size is expected to be worth around USD 2,168.1 Billion by 2032 from USD 1,180.0 Billion in 2023, growing at ...
According to a recent report by Market.us, the Global Drug of Abuse Testing Market size is expected to be worth around USD 11 ...
According to a recent report by Market.us, the Global Restorative Dentistry Market size is expected to be worth around USD 35 Billion by 2032 from USD 19 Billion in 2023, growing at a CAGR of 7.4% ...
According to a recent report by Market.us, the Global Biohacking Market size is expected to be worth around USD 83 Billion by 2032 from USD 19 Billion in 2023, growing at a CAGR of 18.4% during the ...
According to a recent report by Market.us, the Global Protein Engineering Market size is expected to be worth around USD 9,,329 Million by 2033 from USD 3,057 Million in 2023, growing at a CAGR of 13.
Annual ReportAsklepios Group: Asklepios shows resilience in 2023 financial year 25.04.2024 / 10:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Asklepios Group: ...
According to a recent report by Market.us, the Global Biosimulation Market size is expected to be worth around USD 10.1 Billion by 2032 from USD 3.3 Billion in 2023, growing at a CAGR of 13.7% during ...
According to a recent report by Market.us, the Global Vascular Grafts Market size is expected to be worth around USD 5.7 Billion by 2032 from USD 3.3 Billion in 2023, growing at a CAGR of 6.4% during ...
Preliminary Results/Annual ResultsMPH Health Care AG: Preliminary IFRS result 2023 Equity increases by almost 30 million euros to 251.0 million euros, which corresponds to 58.62 euros per share. EBIT ...
According to a recent report by Market.us, the Global Interventional Cardiology Devices Market size is expected to be worth around USD 38 Billion by 2032 from USD 19 Billion in 2023, growing at a CAGR ...
According to a recent report by Market.us, the Global Diabetes Devices Market size is expected to be worth around USD 68.2 Billion by 2032 from USD 26.7 Billion in 2023, growing at a CAGR of 11.3% ...
AllianceMarinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios 25.04.2024 / 07:45 CET/CESTThe issuer is solely responsible for the content of this ...